skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
PEP-CMV Vaccine (Code C107243)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: PEP-CMV Vaccine

Definition: A peptide vaccine derived from cytomegalovirus (CMV) antigens with potential immunostimulating activity. Intradermal administration of the PEP-CMV vaccine may stimulate the immune system to mount a specific helper and cytotoxic T-lymphocyte (CTL) response against CMV-infected tumor cells. Infection with the herpesvirus CMV may play a significant role in tumor cell initiation and progression as well as chemoresistance.

Display Name: PEP-CMV Vaccine

Label: PEP-CMV Vaccine

NCI Thesaurus Code: C107243 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL449497  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
PEP-CMV Vaccine

External Source Codes: 
PDQ Closed Trial Search ID 750850
PDQ Open Trial Search ID 750850 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C107243
Contributing_Source CTRP
Semantic_Type Amino Acid, Peptide, or Protein
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom